These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 23504554

  • 1. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
    Li L, Wu J, Sima X, Bai P, Deng W, Deng X, Zhang L, Gao L.
    Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
    Pan XM, Sun RF, Li ZH, Guo XM, Qin HJ, Gao LB.
    Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
    [Abstract] [Full Text] [Related]

  • 6. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm.
    Li L, Sima X, Bai P, Zhang L, Sun H, Liang W, Liu J, Zhang L, Gao L.
    Clin Dev Immunol; 2012 Apr; 2012():567586. PubMed ID: 22844323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z.
    Int J Cancer; 2011 Jan 15; 128(2):412-7. PubMed ID: 20309940
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
    Chen LL, Shen Y, Zhang JB, Wang S, Jiang T, Zheng MQ, Zheng ZJ, Chen CX.
    Genet Mol Res; 2016 Oct 05; 15(4):. PubMed ID: 27808368
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
    Bulibu J, Wang W, Tang Y, Li N, Saifuding K.
    Pathol Oncol Res; 2019 Jan 05; 25(1):421-427. PubMed ID: 29270777
    [Abstract] [Full Text] [Related]

  • 17. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
    Hashemi M, Danesh H, Bizhani F, Narouie B, Sotoudeh M, Nouralizadeh A, Sharifiaghdas F, Bahari G, Taheri M.
    Cancer Biomark; 2017 Jan 05; 18(2):155-159. PubMed ID: 27983526
    [Abstract] [Full Text] [Related]

  • 18. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
    Gao LB, Li LJ, Pan XM, Li ZH, Liang WB, Bai P, Zhu YH, Zhang L.
    Biol Chem; 2013 Mar 05; 394(3):415-20. PubMed ID: 23183747
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.